Eckhard von Keutz

Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone

Eckhard von Keutz, Gerhard Schlüter · Journal of Antimicrobial Chemotherapy · 1999 · 73 citations · Full text

Pharmacy, Pharmacology, Toxicology +17

Preclinical safety evaluation of cerivastatin, a novel HMG-CoA reductase inhibitor

Eckhard von Keutz, Gerhard Schlüter · The American Journal of Cardiology · 1998 · 57 citations

Medicine, Medicinal Chemistry, Pharmacology +4

Effects of ciprofloxacin on joint cartilage in immature dogs immediately after dosing and after a 5-month treatment-free period

Eckhard von Keutz, Christine Rühl-Fehlert, W. Drommer et al. · Archives of Toxicology · 2004 · 32 citations

Medicine, Orthopedic Surgery, Veterinary Pharmacology +12

Photo-chemically induced DNA effects in the comet assay with epidermal cells of SKH-1 mice after a single oral administration of different fluoroquinolones and 8-methoxypsoralen in combination with exposure to UVA

Uta Wirnitzer, Nicole Gross-Tholl, B. Herbold et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2006 · 23 citations

Pharmacy, Dermatology, Toxicology +17

Cerivastatin (BAY w 6228): A Novel HMG‐CoA Reductase Inhibitor

J. Kuhlmann, Wolfgang Mück, Hilmar Bischoff et al. · Cardiovascular Drug Reviews · 1998 · 19 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +3